XBP1 and cystic fibrosis: As expected, the two inhibitors showed their potent suppressive effects on XBP1s(Figure 6B); however, inhibition of the IRE1α-XBP1 pathway only reduced the transcription levels of IL-6, but not TNF in CF M1 macrophages (Figure 6B).